Innov’nCare is a deeptech startup developing a next-generation therapeutic vectorization platform. Its mission: to enable the precise delivery of treatments to stem cells — including cancer stem cells — to enhance therapeutic efficacy and long-term outcomes.
Innov’nCare was co-founded by two scientists with complementary backgrounds: Claire Lépinoux-Chambaud, PhD in Neuroscience and co-author of the patent protecting the developed technology, and Clément Sanchez, PhD in Medicinal Chemistry. Together, they bring cross-disciplinary expertise in medicinal chemistry, cell biology, pharmaceutical and pharmacological development, and analytical sciences. They are jointly developing a unique platform capable of selectively delivering therapeutic agents to stem cells, the most resistant and critical cell populations in a wide range of diseases, particularly cancers.
This breakthrough opens new avenues for targeted and personalized therapies, while minimizing side effects.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Institut De Biologie En Santé Iris-1 47-49 Rue Des Capucins, Angers,pays De La Loire 49100,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Cancer, Stem cells, Vectorization, pediatric cancer, neurodegenerative diseases, Nanomedicines, Rare diseases, Brain tumors, Peptide, Neurooncology.
- HQ
- Angers, Pays de la Loire
Innov'ncare Questions
Innov'Ncare's LinkedIn profile is https://fr.linkedin.com/company/innov-ncare
Innov'Ncare has
1 employees.
View email and phone details for 1
employees at Innov'Ncare.
Innov'Ncare's industry is
Biotechnology Research
Innov'Ncare's top competitors are
M.i.m - Montpellier Immobilier Méditerranée,
Yomi Pharma,
Areltys,
Biwako,
Letsee Imaging,
Orinova,
Recobia Therapeutics,
Gmt Science,
Captur Umr 1308,
Neolys Diagnostics.
Innov'Ncare's categories are Biotechnology Research
Innov'Ncare's founding year is 2025
